These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 23611514)

  • 21. Progress and challenges in generating functional hematopoietic stem/progenitor cells from human pluripotent stem cells.
    Liu S; Xu Y; Zhou Z; Feng B; Huang H
    Cytotherapy; 2015 Apr; 17(4):344-58. PubMed ID: 25680303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Umbilical cord blood-derived very small embryonic like stem cells (VSELs) as a source of pluripotent stem cells for regenerative medicine.
    Ratajczak MZ; Suszynska M; Pedziwiatr D; Mierzejewska K; Greco NJ
    Pediatr Endocrinol Rev; 2012 Mar; 9(3):639-43. PubMed ID: 22523831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Large scale production of stem cells and their derivatives.
    Zweigerdt R
    Adv Biochem Eng Biotechnol; 2009; 114():201-35. PubMed ID: 19513633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inability of human induced pluripotent stem cell-hematopoietic derivatives to downregulate microRNAs in vivo reveals a block in xenograft hematopoietic regeneration.
    Risueño RM; Sachlos E; Lee JH; Lee JB; Hong SH; Szabo E; Bhatia M
    Stem Cells; 2012 Feb; 30(2):131-9. PubMed ID: 22131151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retroviral transduction of hematopoietic progenitors derived from human embryonic stem cells.
    Menendez P; Wang L; Cerdan C; Bhatia M
    Methods Mol Biol; 2006; 331():201-20. PubMed ID: 16881519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The marrow stem cell: the continuum.
    Quesenberry PJ; Colvin GA; Abedi M; Lambert JF; Moore B; Demers D; Greer D; McAuliffe C; Dooner M; Lum LG; Badiavas E; Falanga V
    Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S19-22. PubMed ID: 12931234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Directed differentiation of pluripotent stem cells: from developmental biology to therapeutic applications.
    Irion S; Nostro MC; Kattman SJ; Keller GM
    Cold Spring Harb Symp Quant Biol; 2008; 73():101-10. PubMed ID: 19329573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Challenges and strategies for generating therapeutic patient-specific hemangioblasts and hematopoietic stem cells from human pluripotent stem cells.
    Peters A; Burridge PW; Pryzhkova MV; Levine MA; Park TS; Roxbury C; Yuan X; Péault B; Zambidis ET
    Int J Dev Biol; 2010; 54(6-7):965-90. PubMed ID: 20563986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Application of Pluripotent Stem Cells: An Alternative Cell-Based Therapy for Treating Liver Diseases?
    Tolosa L; Pareja E; Gómez-Lechón MJ
    Transplantation; 2016 Dec; 100(12):2548-2557. PubMed ID: 27495745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospects for the manufacture of red cells for transfusion.
    Mountford J; Olivier E; Turner M
    Br J Haematol; 2010 Apr; 149(1):22-34. PubMed ID: 20151974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A portable platform for stepwise hematopoiesis from human pluripotent stem cells within PET-reinforced collagen sponges.
    Sugimine Y; Niwa A; Matsubara H; Kobayashi K; Tabata Y; Heike T; Nakahata T; Saito MK
    Int J Hematol; 2016 Dec; 104(6):647-660. PubMed ID: 27599982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation of pluripotent stem cells for regenerative medicine.
    Li K; Kong Y; Zhang M; Xie F; Liu P; Xu S
    Biochem Biophys Res Commun; 2016 Feb; 471(1):1-4. PubMed ID: 26851367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Artificial reprogramming of human somatic cells to generate pluripotent stem cells: a possible alternative to the controversial use of human embryonic stem cells.
    Romano G
    Drug News Perspect; 2008 Oct; 21(8):440-5. PubMed ID: 19034350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Directed Differentiation of Primitive and Definitive Hematopoietic Progenitors from Human Pluripotent Stem Cells.
    Dege C; Sturgeon CM
    J Vis Exp; 2017 Nov; (129):. PubMed ID: 29155741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation of embryonic stem cells towards hematopoietic cells: progress and pitfalls.
    Tian X; Kaufman DS
    Curr Opin Hematol; 2008 Jul; 15(4):312-8. PubMed ID: 18536568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Differentiation potential of stem cells from bone marrow].
    Kronenwett R; Haas R
    Med Klin (Munich); 2006 Mar; 101 Suppl 1():182-5. PubMed ID: 16802550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deciphering the hierarchy of angiohematopoietic progenitors from human pluripotent stem cells.
    Slukvin II
    Cell Cycle; 2013 Mar; 12(5):720-7. PubMed ID: 23388453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Towards hematopoietic reconstitution from embryonic stem cells: a sanguine future.
    McKinney-Freeman SL; Daley GQ
    Curr Opin Hematol; 2007 Jul; 14(4):343-7. PubMed ID: 17534159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protagonist or antagonist? The complex roles of retinoids in the regulation of hematopoietic stem cells and their specification from pluripotent stem cells.
    Grace CS; Mikkola HKA; Dou DR; Calvanese V; Ronn RE; Purton LE
    Exp Hematol; 2018 Sep; 65():1-16. PubMed ID: 29981365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.